HEAD AND NECK CANCERS

Clinical trials for HEAD AND NECK CANCERS explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK CANCERS trials appear

Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 2 Not yet finished but already full! 1 Completed 3 Terminated 2

New drug combo targets Hard-to-Treat cancers

Disease control Ongoing

This early-stage study tests a new drug called IDE161, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like breast, ovarian, prostate, or lung cancer). The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. Ab…

Matched conditions: HEAD AND NECK CANCERS

Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control

Last updated Jun 17, 2026 01:27 UTC

HEAD AND NECK CANCERS

Get alerted when new HEAD AND NECK CANCERS trials appear

New drug combo targets Hard-to-Treat cancers